Feng Wu

Professor Feng Wu received his medical training at Chongquing Medical University in China. In 1988 hebegan his research career in high intensity focused ultrasound (HIFU) therapy, and developed his ownclinical HIFU device, with his work largely dedicated to treating solid tumors, including those of the liver,kidney, breast, pancreas, uterus, bone, and soft tissues. Until now Professor Wu and his teams havetreated more than 50,000 patients, the largest population of HIFU treated cancer patients in the world. In 2002, Professor Wu was invited to help establish the first clinical HIFU Unit in the United Kingdom, andto assist in running clinical HIFU trials for the treatment of tumour patients in Churchill Hospital, OxfordUniversity Hospitals. His pivotal role in bringing this emerging technology to the UK has resulted in himbecoming the first Chinese-trained clinician ever to be entered directly onto the specialist register in theUK - under the newly created Specialty of High Intensity Focused Ultrasound Therapy. Professor Wu is currently working as HIFU Consultant at Oxford University Hospitals, and also serving asSenior Clinical Scientist at Nuffield Department of Surgical Sciences, University of Oxford. He haspublished more than 200 papers in peer-reviewed journals and seven book chapters related to HIFUtherapy, and served as Editor-in-Chief in the World Journal of Surgical Procedure and Editorial BoardMember in nine peer-reviewed journals. He was one of the founders for International Society forTherapeutic Ultrasound (ISTU), and was selected as Secretary-General of ISTU for six consecutive years(2001-2006). Professor Wu received the Society’s William and Francis Fry Award in 2013, and served asHonorary Symposium President for the 4th International Symposium on Current and Future Applicationsof Focused Ultrasound in 2014.